C
CPRX

Covestor’s Catalyst Pharmaceutical CPRX Stock Holding History

Covestor’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$204K Sell
8,219
-8,447
-51% -$201K 0.14% 107
2025
Q4 		$389K Buy
16,666
+955
+6% +$21.3K 0.2% 64
2025
Q3 		$310K Buy
15,711
+4,964
+46% +$102K 0.17% 76
2025
Q2 		$233K Buy
10,747
+10,221
+1,943% +$241K 0.14% 126
2025
Q1 		$13K Buy
526
+29
+6% +$653 0.01% 1340
2024
Q4 		$11K Sell
497
-34
-6% -$730 0.01% 1468
2024
Q3 		$11K Sell
531
-245
-32% -$4.54K 0.01% 1484
2024
Q2 		$12K Buy
776
+8
+1% +$125 0.01% 1403
2024
Q1 		$12K Buy
768
+64
+9% +$964 0.01% 1430
2023
Q4 		$12K Buy
704
+118
+20% +$1.61K 0.01% 1418
2023
Q3 		$7K Sell
586
-86
-13% -$1.15K 0.01% 1610
2023
Q2 		$9K Sell
672
-1,631
-71% -$23.5K 0.01% 1489
2023
Q1 		$38K Buy
2,303
+107
+5% +$1.76K 0.03% 813
2022
Q4 		$41K Sell
2,196
-54
-2% -$831 0.03% 799
2022
Q3 		$29K Sell
2,250
-2,280
-50% -$27K 0.03% 898
2022
Q2 		$32K Sell
4,530
-348
-7% -$2.55K 0.03% 863
2022
Q1 		$40K Buy
4,878
+4,316
+768% +$30.5K 0.03% 867
2021
Q4 		$4K Buy
+562
New +$3.7K 0.01% 1376

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Covestor's CPRX Position: Q1 2026 in Review

Covestor reduced its Catalyst Pharmaceutical (CPRX) stake by 51% in Q1 2026, selling an estimated $201K and leaving 8,219 shares worth $204K. The position accounts for 0.14% of the portfolio, ranked #107.

Covestor first reported a position in CPRX in Q4 2021 and has held it in 18 quarters since. The position peaked at $389K in Q4 2025. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Covestor held 8,219 shares of Catalyst Pharmaceutical worth $204K as of Q1 2026.
  • Covestor sold 8,447 Catalyst Pharmaceutical shares in Q1 2026, an estimated $201K.
  • Catalyst Pharmaceutical made up 0.14% of Covestor's portfolio in Q1 2026, its #107 holding.
  • Covestor first reported a position in Catalyst Pharmaceutical in Q4 2021 and has held it in 18 quarters since.
  • Covestor's Catalyst Pharmaceutical position peaked at $389K in Q4 2025.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.